Vitamin D Supplementation in Acne
- Disease/Condition
- Acne Vulgaris
- Drug/Device/Intervention
- D Max Drops
- Study type
- Interventional
- Intervention type
- dietary supplement
- Primary sponsor
- HITEC-Institute of Medical Sciences
- Location
- Islamabad, Pakistan
- Phase
- N/A
- Start date
- Dec 01, 2023
- End date
- Mar 01, 2024
- Enrollment
- 58 participants
Efficacious
The goal of this clinical trial is to compare in acne vulgaris patients. The main question it
 aims to answer is:
 
 • To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment,
 following a 2-month treatment regimen that includes vitamin D supplementation compared to
 conventional (systemic azithromycin and topical retinoid) treatment alone.
 
 Participants will receive vitamin D supplements in addition to capsule Azithromycin and
 topical retinoid.
 
 Researchers will compare groups to determine efficacy of Vitamin D supplements in the
 treatment of Acne vulgaris.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06141330
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06141330 through Pure Global AI's free database. This phase not specified trial is sponsored by HITEC-Institute of Medical Sciences and is currently Not yet recruiting. The study focuses on Acne Vulgaris. Target enrollment is 58 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.